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Aim: Alleviation of the pain resulting from injection of rocuronium during anesthesia is still an unsolved problem. We aimed to
compare the analgesic effects of sufentanil, tramadol, meperidine, and lidocaine on the pain from injection of rocuronium.
Materials and methods: This prospective randomized double-blind study included 200 patients with ASA I–II. After a tourniquet was
applied to the forearm, patients received 50 mg of tramadol (group T), 10 µg of sufentanil (group S), 40 mg of meperidine (group M),
or 30 mg of lidocaine (group L). The tourniquet was released after 20 s and rocuronium was injected over 10 to 15 s. The patients were
asked whether the injection caused pain or not. Side effects were recorded.
Results: The incidence of injection pain was highest in group T. Severe pain was most frequently encountered in group S. Lidocaine was
the most effective analgesic in alleviating the injection pain while sufentanil was the least effective drug (P < 0.05). Erythema was the
common side effect at the injection site in group M and arrhythmia was observed in group T.
Conclusion: The analgesic effect of meperidine was not significantly superior to that of the other drugs. Lidocaine seemed to be the
most effective analgesic drug for minimizing the pain due to rocuronium injection.
Key words: Rocuronium, injection pain, opioids, female patients

1. Introduction
Rocuronium bromide is a steroidal nondepolarizing
neuromuscular blocking agent and is characterized by
rapid to intermediate onset of action, depending on
dose, and an intermediate duration of action. It is used
for precurarization as a priming neuromuscular relaxant
agent during induction of anesthesia (1,2). Pain due to
injection of rocuronium is a common adverse effect,
occurring in 50%–80% of patients (3). Pain accompanied
by a burning sensation may be particularly severe (4,5).
Shevchenko et al. (6) showed that intravenous (IV)
injection of rocuronium might cause significant limb
withdrawal or generalized movement in patients even
more than with IV propofol, which could be explained
by the presence of intense nociception even during
anesthesia. Several studies have been designed to
determine the effective concentration of fentanyl and
lidocaine to efficiently eliminate injection pain caused by
propofol and rocuronium (5,7,8). It has been shown that
* Correspondence: mehtaphonca@hotmail.com

moderate and severe pain could be treated by tramadol,
which is a synthetic analgesic (9). Pang et al. (10) showed
that propofol injection pain could be significantly
reduced by local anesthetic activity of tramadol and
lidocaine. On the other hand, Tsai et al. (11) suggested
that the local anesthetic-type effect of tramadol on sciatic
nerves of rats was likely to be related to neural conduction
blockage. It has been shown that meperidine had a local
analgesic effect similar to lidocaine and is more effective
than morphine and fentanyl in reducing the pain on
propofol injection but its mechanism of action is still
unknown (12). To date, various strategies have been
drawn up to alleviate discomfort in many studies, but
none of them has evaluated the effect of meperidine on
rocuronium injection pain. The present study aimed to
investigate the effectiveness of 3 commonly used opioids
(sufentanil, tramadol, and meperidine) in comparison
with lidocaine in minimizing the injection pain due to
rocuronium.
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2. Materials and methods
After obtaining ethical committee approval and informed
consent from patients, 200 female patients between 17 and
71 years of age were included in a prospective randomized
double-blind study. All patients with a physical class
of American Society of Anesthesiologists (ASA) I or II
underwent elective gynecologic surgery. Patients with
neurological deficits, thrombophlebitis, chronic pain
syndrome, difficult venous access, or clinical conditions
that contraindicated the administration of any of the drugs
used in the study were excluded. Premedication was not
used. After heart rate, noninvasive blood pressure, and pulse
oximetry monitoring, a 20-gauge cannula was inserted
into the vein on the dorsum of the hand for infusion of
the crystalloid solutions and other medications. The dorsal
vein of the other hand was also catheterized as an alternative
venous access. Mean arterial pressure (MAP) and heart
rate (HR) were recorded on arrival at the operating theater
(baseline), and before and after endotracheal intubation.
A tourniquet was applied to the arm and inflated up to
70 mmHg to keep the drug within the vein. Two hundred
patients were randomly assigned to 4 groups of 50 patients
each using sealed envelopes with group names. Then the
patients randomly received tramadol 50 mg (group T, n
= 50), sufentanil 10 µg (group S, n = 50), meperidine 40
mg (group M, n = 50), or lidocaine 30 mg (group L, n =
50) intravenously at ambient operating room temperature
(20–22 °C). Physiological saline was added to make the
drug solutions up to 3 mL. The tourniquet was released 20
s later and an intubating dose of rocuronium 0.6 mg kg–1 at
room temperature was injected over 10–15 s. Each patient
was questioned every 5 s about the presence of any pain or
discomfort in the arm by an anesthetist who was unaware
of the injected drug. Patients were also observed for signs
of limb withdrawal, strong vocal response, grimacing,
and crying. Patients’ response was evaluated by use of a

4-point verbal analogue scale as shown in Table 1. Twentyfive seconds after the administration of rocuronium, 5
mg kg–1 of thiopental was administered intravenously.
The patients were tracheally intubated and anesthesia was
maintained with sevoflurane in oxygen/N2O. The injection
site was checked for any complications such as erythema,
swelling, or allergic reactions at the end of operation by an
anesthesiologist who did not know which drug had been
injected.
Statistical analyses were performed using SPSS 11.0
for Windows. Patients’ characteristics and hemodynamic
variables were analyzed using one-way ANOVA. Pain
scores and side effects were analyzed by the chi-squared
test. A P value of 0.05 was considered statistically
significant.
3. Results
There was no significant difference in terms of
demographic data (Table 2). Grades of pain due to
injection of rocuronium are presented in Table 3. The
incidence of pain in group T was higher than that in group
S, whereas the intensity of pain was higher in group S. Pain
incidence was 82% (n = 41) in group M. The analgesic
effect of meperidine was not significantly superior when
compared with the other medications. Lidocaine was the
most effective and sufentanil was the least effective drug
in the prevention of injection pain due to rocuronium (P
< 0. 05).
None of the patients suffered from muscle weakness
before 30 s. Erythema at the injection site was significantly
more common (n = 18; 36%) in group M (P < 0.05).
Arrhythmia was observed in 6 (12%) patients in group
T (P < 0.05). No complications such as pain, swelling, or
allergic reactions were observed at the injection site during
the first 24 h following the operation.

Table 1. Assessment of pain during injection of rocuronium.
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The degree of pain

Response

None (0)

Negative response to questioning

Mild (1)

Pain reported in response to questioning only, without any
behavioral signs

Moderate (2)

Pain reported in response to questioning and accompanied
by a behavioral sign, or pain reported spontaneously without
questioning

Severe (3)

Strong vocal response or response accompanied by facial
grimacing, arm withdrawal, or tears
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Table 2. Demographic characteristics of all patients.
Group T
(n = 50)

Group S
(n = 50)

Group M
(n = 50)

Group L
(n = 50)

Age (years)

42.3 ± 11.5 (17–60)

40.1 ± 11.8 (19–68)

38 ± 11.4 (18–56)

40.1 ± 11.4 (20–71)

Height (cm)

160.7 ± 4.9 (150–174)

161.1 ± 5.6 (150–170)

160.2 ± 6.6 (143–175)

161.3 ± 5.7 (150–175)

Weight (kg)

70 ± 13.2 (49–110)

68.7 ± 13.8 (40–103)

69.2 ± 13.2 (45–110)

69.9 ± 14.8 (45–117)

ASA I/II (n)

32/18

35/15

32/18

36/14

All data are expressed as mean ± standard deviation (minimum–maximum) or numbers
Table 3. Distributions according to intensity of pain.
Group T
(n = 50)

Group S
(n = 50)

Group M
(n = 50)

Group L
(n = 50)

3 (6%)

4 (8%)

9 (18%)

21 (42%)*

Mild pain (1)

24 (48%)

10 (20%)

22 (44%)

22 (44%)

Moderate pain (2)

21 (42%)

30 (60%)

19 (38%)

7 (14%)*

2 (4%)

6 (12%)

0 (0%)

0 (0%)

No pain (0)

Severe pain (3)
n = number of patients.
*P < 0.05 versus other groups

Table 4. Intraoperative adverse events in all patients.
Group T
(n = 50)

Group S
(n = 50)

Group M
(n = 50)

Group L
(n = 50)

6 (12%)*

1 (2%)

1 (2%)

1 (2%)

Flushing

0

0

1 (2%)

1 (2%)

Erythema

0

30 (60%)

19 (38%)

7 (14%)*

Arrhythmia

n = number of patients.
*P < 0.05 versus other groups

4. Discussion
In the present study, the analgesic effect of lidocaine
was significantly superior compared with the other
commonly used opioids in alleviating injection pain due
to rocuronium.
Rocuronium is a steroidal nondepolarizing muscle
relaxant. It has a time of onset from rapid to intermediate
depending on the dose and an intermediate duration of
action. Moreover, larger doses of rocuronium (up to 2
mg kg–1) may be useful for rapid tracheal intubation if
succinylcholine is contraindicated (13). The pain related
to the administration of rocuronium is a common adverse
effect and distressing situation for patients. The exact

mechanism that evokes pain with an intravenous injection
of rocuronium is still unknown. Klement et al. (14)
showed that acidic and alkaline solutions elicited pain at
the pH values of <4 and >11. Rocuronium bromide is an
isotonic solution with a pH of 4.0. Injection pain can be
explained by the effect of the acidic pH of rocuronium (15).
Previous studies showed that pretreatment using lidocaine
or fentanyl or an injection of a mixture of rocuronium
and sodium bicarbonate was effective in reducing the
incidence of pain (15–17). Shevchenko et al. (6) reported
that pretreatment with lidocaine and venous occlusion
decreased the incidence of withdrawal movements to
46%. It is possible to study the peripheral action of drugs
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without the central effect by venous occlusion similar
to Bier block (18). Cheong and Wong (15) showed that
lidocaine 10 and 30 mg reduced the incidence and severity
of rocuronium injection pain but the larger dose was more
effective. Akkaya et al. (19) found that lidocaine 30 mg was
more effective than ketamine for decreasing the severity of
pain and withdrawal movements induced by rocuronium
injection. Memis et al. (20) showed that pretreatment
with lidocaine by venous occlusion was more effective
than with ondansetron, tramadol, or fentanyl and they
determined that 30 mg of lidocaine was the most effective
dose. Similarly, lidocaine 30 mg was found to be the most
effective dose in the present study.
Tramadol is a centrally acting analgesic that inhibits
reuptake of serotonin and noradrenalin and this probably
explains the mechanism of action. Structurally it is not
an opiate but may display some opioid characteristics.
Nevertheless, the analgesic effects of tramadol are not
completely reversed by opioid antagonists (21). Pang et al.
(21,22) demonstrated that IM injection of 25 mg of tramadol
had a local anesthetic effect, and, when it was compared
with lidocaine, IV injection of tramadol 50 mg prevented
injection pain due to propofol. However, in another
clinical study, addition of tramadol to levobupivacaine did
not improve the block quality (23). It has been suggested
that IV injection of tramadol 50 mg reduced the severity
of pain due to injection of rocuronium (20). Our study
revealed that tramadol 50 mg did not completely eliminate
the injection pain of rocuronium.
Joshi and Whitten (5) showed that 100 µg of IV fentanyl
and 2 mg of midazolam prevented the pain resulting from
the injection of a defasciculating dose of rocuronium
in adults. Singh et al. (24) found that the intensity of
rocuronium injection pain could be reduced with fentanyl
or sufentanil administration in most patients falling into
the mild pain group. In our study, sufentanil was the least
effective drug.
We used meperidine because no study had been
conducted on administration of meperidine to attenuate
the pain due to injection of rocuronium. Meperidine,

which has local anesthetic activity, has a molecular weight
and pKa similar to lidocaine compared with other opioids
(25). Pang et al. (12) showed that meperidine was also
effective in reducing the severity of pain resulting from
injection of propofol. Jaffe and Rowe (26) reported that
only meperidine had local anesthetic effects compared with
fentanyl and sufentanil and both sufentanil and fentanyl
were not effective in neural conduction of dorsal root
axons. We found that the analgesic effect of meperidine
was not significantly higher than that of the other agents.
Lidocaine 30 mg was the most effective agent in reducing
the injection pain due to rocuronium.
Regarding side effects, a few minutes following the
injection of meperidine local erythema was observed in
36% (n = 18) of patients but disappeared spontaneously
without any medication, which could be explained by
histamine release related to meperidine administration.
Within the first 24 h following the operation, the
injection site was checked for any complications, such
as pain, swelling, or allergic reactions, but none were
observed. Arrhythmia was observed in 6 (12%) patients
in the tramadol group. Wagner et al. (27) reported that
preoperative administration of tramadol resulted in an
increase in troponin I levels during the postoperative period.
That exacerbation could be mediated via serotoninergic
effects of tramadol and excessive serotoninergic activity
(serotonin syndrome), causing coronary ischemia (27).
Mencke et al. (28) suggested that female patients
reported more pain due to injection of rocuronium than
did male patients. Recent reports have shown that women
had less tolerance to many types of nociceptive stimuli
than men (29,30). In our study, even in the lidocaine
group, 58% of the patients suffered from pain, which could
be explained by the fact that all of the patients recruited for
the study were female.
In conclusion, the analgesic effect of meperidine was
not significantly superior to that of the other analgesic
agents. Our results showed that lidocaine was the most
effective drug, whereas sufentanil was the least effective for
alleviating the pain resulting from injection of rocuronium.
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